Trade Summary

6 days ago, Casdin Capital, LLC, serving as Dir at GeneDx Holdings Corp. (WGS), purchased 200,000 shares at $55.55 per share, for a total transaction value of $11,109,565.00. Following this transaction, Casdin Capital, LLC now holds 3,707,164 shares of WGS.

This purchase represents a 5.70% increase in Casdin Capital, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 8, 2026 at 5:25 PM ET, 4 days after the trade was made.

GeneDx Holdings Corp. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.